Cargando…

Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells

PURPOSE: Despite advancements in its treatment, gastric cancer continues to be one of the leading causes of cancer deaths worldwide. Adoptive transfer of chimeric antigen receptor-modified T cells is a promising antitumor therapy for many cancers. The purpose of this study was to construct a chimeri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xianqiang, Sun, Meili, Yu, Shui, Liu, Kai, Li, Xirui, Shi, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622417/ https://www.ncbi.nlm.nih.gov/pubmed/26543378 http://dx.doi.org/10.2147/OTT.S91122

Ejemplares similares

Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
por: Gwee, Yong Xiang, et al.
Publicado: (2022)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
por: Zöller, Tobias, et al.
Publicado: (2018)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Human NKG2D-ligands: cell biology strategies to ensure immune recognition
por: Fernández-Messina, Lola, et al.
Publicado: (2012)

Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)

Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation
por: Leung, Wai-Hang, et al.
Publicado: (2013)

Construction and evaluation of a novel humanized HER2-specific chimeric receptor
por: Sun, Meili, et al.
Publicado: (2014)

Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
por: Baragaño Raneros, Aroa, et al.
Publicado: (2014)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
por: Antonangeli, Fabrizio, et al.
Publicado: (2017)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

Molecular Bases for the Regulation of NKG2D Ligands in Cancer
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

NKG2D ligands mediate immunosurveillance of senescent cells
por: Sagiv, Adi, et al.
Publicado: (2016)

NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
por: Fan, Juan, et al.
Publicado: (2021)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
por: Zhang, Yi, et al.
Publicado: (2023)

Smoking induces expression of ligands of the immune receptor NKG2D
por: Ospelt, Caroline, et al.
Publicado: (2012)

NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013)

NKG2D and Its Ligands: “One for All, All for One”
por: Zingoni, Alessandra, et al.
Publicado: (2018)

The NKG2D ligand ULBP4 is not expressed by human monocytes
por: Lazarova, Mariya, et al.
Publicado: (2021)

Editorial: The interaction of NKG2D and its ligands in health and diseases
por: Gaudieri, Silvana, et al.
Publicado: (2022)

Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
por: Soriani, Alessandra, et al.
Publicado: (2013)

LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target
por: Kang, Xi, et al.
Publicado: (2021)

Issues on peritoneal metastasis of gastric cancer: an update
por: Wang, Zhen, et al.
Publicado: (2019)

Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis
por: Shen, Xianhe, et al.
Publicado: (2023)

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
por: Zhang, Jinyu, et al.
Publicado: (2015)

The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands
por: Zuo, Jianmin, et al.
Publicado: (2018)

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
por: Schmiedel, Dominik, et al.
Publicado: (2018)

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
por: Zingoni, Alessandra, et al.
Publicado: (2020)

Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
por: Jones, Amber B., et al.
Publicado: (2022)

STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression
por: Le Bert, Nina, et al.
Publicado: (2014)

Editorial: Peritoneal metastasis of gastric cancer
por: Wang, Shuyi, et al.
Publicado: (2023)

Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
por: Jimenez-Perez, Miriam I, et al.
Publicado: (2012)

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
por: Zocchi, Maria Raffaella, et al.
Publicado: (2015)

Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
por: Nice, Timothy J., et al.
Publicado: (2009)

Manipulation of NKG2D Ligands by Cytomegaloviruses: Impact on Innate and Adaptive Immune Response
por: Slavuljica, Irena, et al.
Publicado: (2011)

NKG2D and its ligands: active factors in the outcome of solid organ transplantation?
por: Suárez-Álvarez, Beatriz, et al.
Publicado: (2011)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
por: Thompson, Thornton W, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rruqhmutpn12ibd1gqccqknb27